RSA Viewpoints
Inspiring Leaders | Jo Pisani Part Two
The professional world has evolved at exponential pace since I started my first role at BP and more women are pushing forward and moving...
Inspiring Leaders | Jo Pisani Part One
Early influences on my journey into science and leadership I always liked the sciences at school, and I also loved to take things apart...
My experience as a research intern during the pandemic
Like so many of my fellow undergraduates earlier this year, I felt disheartened and discouraged by the volume of rejected internship applications filling my...
From academia to industry: insights on how to make the move
Making the transition from academia to industry can be a challenging step, both for new graduates and seasoned researchers. In this blog, Daniel Cox,...
Further reflections from a Headhunter in Life Sciences who is (still) a realistic optimist
We all need a RQ (Reflective Intelligence Quotient) – we already have embraced IQ and EQ or ??? Having more time (no commute into...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 2
In volume 1 of this blog, I looked at the tension caused by the growing demands on medical research charities and their heightened financial...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 1
As we come out of the first wave of the Covid-19 pandemic, the issues affecting the Boards of medical research charities are, in many...
Reflections from a Headhunter in Life Sciences who is a realistic optimist – we need a new social contract!
In my self-isolating work from home arrangement since March, I am humbled that I have work to do and people to engage with. It’s...
What should pharma companies learn from the pandemic? Volume 2
Accelerated Evolution | The “New Normal” For the Pharma industry, Covid-19 has been a catalyst like no other. Even HIV in the 1980s wasn’t...
Never has the life sciences sector been more important – it’s time for Boards to raise their game
In recent conversations with investors, availability of the right people to join biotech Boards has come up as a recurring theme and the prevailing...
What should pharma companies learn from the pandemic? Volume 1
Now is the opportunity for leaders to create essential change
I’m often asked: “How are the best leaders behaving?” I observe that quicker decision-making, simplicity...
Key Learnings from the Coronavirus Challenge and innovating for a sustainable future
The life science sector is under extreme pressure to meet the global need for better, faster therapies to combat COVID-19 and The BIA is...
Interim managers can help when international travel is restricted
As the world faces an unprecedented global shutdown amid the COVID-19 pandemic, for life sciences companies it’s in the interests of everyone, not least...
IR35 postponement makes Interim Executives an option once again
This week’s government decision to postpone the implementation of the Off-Payroll Tax (IR35) to the private sector until April 2021 is a welcome announcement...
Considerations for leaders: managing teams remotely
Following last week’s announcement by the World Health Organisation that the spread of Covid-19 has officially reached ‘pandemic’ status, more and more companies are...
Could a different approach to head office teams drive better efficiency?
When done right, an interim manager can provide a cost-effective way to access the best talent to deliver a flexible solution, whilst transferring skills...
Nurturing new talent – top 5 benefits of an internship
The job market is becoming more and more competitive. Students who have spent the twilight of their teenage years grinding out essays in College...
JPM 2020 l The changing landscape of global healthcare in the new decade
I was struck by a resounding shift in attitude at this year’s J.P. Morgan Healthcare Conference; less talk, more action. The atmosphere felt more...